Carlo Tanzi | VP of IR & Corporate Communications |
Eric Shaff | President, CEO & Director |
Lisa von Moltke | EVP & Chief Medical Officer |
Matthew Henn | EVP & Chief Scientific Officer |
Chris Shibutani | Cowen |
Melissa Hilton | Goldman Sachs |
Matthew Biegler | Oppenheimer |
Gbola Amusa | Chardan |
John Newman | Canaccord |
Vernon Bernardino | H.C. Wainwright |
Roger Song | Jefferies |
Justin Zelin | Canaccord |
Ladies and gentlemen, thank you for standing by, and welcome to the Seres Therapeutics Q1 Earnings Conference Call. At this time all participants are in a listen mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I must advice you that this conference is being recorded today May 7, 2020.
I would now like to hand the conference over to your speaker for today, Dr.